Company Information & Drug Savings for Regeneron Pharmaceuticals, Inc. Medications
Regeneron Pharmaceuticals is a leading biotechnology company developing transformative medicines for serious diseases. Based in Tarrytown, New York, key products include Eylea (aflibercept) for retinal diseases, Dupixent (dupilumab) for atopic dermatitis, asthma, and other inflammatory conditions, Libtayo (cemiplimab) for cancers, and REGEN-COV for COVID-19. Regeneron’s VelociSuite technology platform accelerates drug discovery and development.
How to Contact Regeneron Pharmaceuticals, Inc.
Phone
1-914-847-7000Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
